Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.

Thanabalasuriar A, Kim J, Gruenheid S.

Microbes Infect. 2013 Sep-Oct;15(10-11):738-44. doi: 10.1016/j.micinf.2013.05.001. Epub 2013 Jun 6.

PMID:
23747681
2.

Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA.

Thanabalasuriar A, Bergeron J, Gillingham A, Mimee M, Thomassin JL, Strynadka N, Kim J, Gruenheid S.

Cell Microbiol. 2012 Aug;14(8):1206-18. doi: 10.1111/j.1462-5822.2012.01789.x. Epub 2012 Apr 12.

PMID:
22432415
3.

The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function.

Kim J, Thanabalasuriar A, Chaworth-Musters T, Fromme JC, Frey EA, Lario PI, Metalnikov P, Rizg K, Thomas NA, Lee SF, Hartland EL, Hardwidge PR, Pawson T, Strynadka NC, Finlay BB, Schekman R, Gruenheid S.

Cell Host Microbe. 2007 Sep 13;2(3):160-71.

4.

Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.

Khan MA, Bouzari S, Ma C, Rosenberger CM, Bergstrom KS, Gibson DL, Steiner TS, Vallance BA.

Infect Immun. 2008 Apr;76(4):1410-22. doi: 10.1128/IAI.01141-07. Epub 2008 Jan 28.

5.

The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.

Thanabalasuriar A, Koutsouris A, Weflen A, Mimee M, Hecht G, Gruenheid S.

Cell Microbiol. 2010 Jan;12(1):31-41. doi: 10.1111/j.1462-5822.2009.01376.x. Epub 2009 Aug 27.

6.

EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.

Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G.

MBio. 2012 Oct 2;3(5). pii: e00317-12. doi: 10.1128/mBio.00317-12. Print 2012.

7.

Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.

Girard F, Crepin VF, Frankel G.

Infect Immun. 2009 Apr;77(4):1304-14. doi: 10.1128/IAI.01351-08. Epub 2009 Feb 2.

9.

Attaching and effacing pathogen-induced tight junction disruption in vivo.

Guttman JA, Li Y, Wickham ME, Deng W, Vogl AW, Finlay BB.

Cell Microbiol. 2006 Apr;8(4):634-45.

PMID:
16548889
10.

Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.

Viswanathan VK, Koutsouris A, Lukic S, Pilkinton M, Simonovic I, Simonovic M, Hecht G.

Infect Immun. 2004 Jun;72(6):3218-27.

11.

Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.

Sham HP, Shames SR, Croxen MA, Ma C, Chan JM, Khan MA, Wickham ME, Deng W, Finlay BB, Vallance BA.

Infect Immun. 2011 Sep;79(9):3552-62. doi: 10.1128/IAI.05033-11. Epub 2011 Jul 11.

12.

Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.

Gruenheid S, Sekirov I, Thomas NA, Deng W, O'Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB.

Mol Microbiol. 2004 Mar;51(5):1233-49.

13.

[Multitalented lymphostatin].

Klapproth JM, Meyer F.

Dtsch Med Wochenschr. 2009 Feb;134(9):417-20. doi: 10.1055/s-0029-1208066. Epub 2009 Feb 17. Review. German.

PMID:
19224428
14.

A type III effector antagonizes death receptor signalling during bacterial gut infection.

Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TW, Mansell A, Riedmaier P, Oates CV, Zaid A, Mühlen S, Crepin VF, Marches O, Ang CS, Williamson NA, O'Reilly LA, Bankovacki A, Nachbur U, Infusini G, Webb AI, Silke J, Strasser A, Frankel G, Hartland EL.

Nature. 2013 Sep 12;501(7466):247-51. doi: 10.1038/nature12524.

16.

Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.

Yen H, Sugimoto N, Tobe T.

PLoS Pathog. 2015 Sep 2;11(9):e1005121. doi: 10.1371/journal.ppat.1005121. eCollection 2015 Sep.

17.

Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium.

Cheng C, Tennant SM, Azzopardi KI, Bennett-Wood V, Hartland EL, Robins-Browne RM, Tauschek M.

Infect Immun. 2009 May;77(5):1936-44. doi: 10.1128/IAI.01246-08. Epub 2009 Mar 2.

18.

Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.

Arbeloa A, Oates CV, Marchès O, Hartland EL, Frankel G.

Infect Immun. 2011 Mar;79(3):1067-76. doi: 10.1128/IAI.01003-10. Epub 2010 Dec 28.

19.

Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.

Long TM, Nisa S, Donnenberg MS, Hassel BA.

Infect Immun. 2014 Jul;82(7):2802-14. doi: 10.1128/IAI.00105-14. Epub 2014 Apr 14.

20.

Citrobacter rodentium: infection, inflammation and the microbiota.

Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G.

Nat Rev Microbiol. 2014 Sep;12(9):612-23. doi: 10.1038/nrmicro3315. Epub 2014 Aug 4. Review.

PMID:
25088150
Items per page

Supplemental Content

Write to the Help Desk